Dr. Lisa Cannon-Albright is the current Chief of the Genetic Epidemiology Program. Dr. Cannon-Albright oversees several genetic studies including prostate, lung, colon, pancreas, brain, and bladder cancers and pelvic organ prolapse, as well as the continued study of the genetics of melanoma and breast cancer.
With help from our collaborators, we identified a familial melanoma susceptibility gene known as p16.
Also, with collaborators, we identified BRCA1 and BRCA2, familial breast cancer susceptibility genes.
The Genetic Epidemiology Program can be traced back to 1973 when Mark Skolnick (then a Ph.D. student at Stanford University) accepted a position at the University of Utah. With aid from the National Cancer Institute, Dr. Skolnick began to study the genetics of cancer in Utah families.
At the time, it was believed that most cancer were caused solely by environmental factors with no familial or genetic component.